(Q38509473)

30 June 2019

review article

1 reference

title

Apolipoprotein A5: Extracellular and Intracellular Roles in Triglyceride Metabolism (English)

1 reference

30 June 2019

1 reference

2

1 reference

14 November 2018

Trudy M Forte

1

1 reference

30 June 2019

publication date

1 January 2015

1 reference

30 June 2019

published in

Current Drug Targets

1 reference

30 June 2019

volume

16

1 reference

30 June 2019

issue

12

1 reference

30 June 2019

page(s)

1274-1280

1 reference

30 June 2019

Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration

cites work

1 reference

12 December 2020

An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing

1 reference

12 December 2020

Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels

1 reference

12 December 2020

A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia

1 reference

12 December 2020

The influence of APOAV polymorphisms (T-1131>C and S19>W) on plasma triglyceride levels and risk of myocardial infarction

1 reference

12 December 2020

ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis.

1 reference

12 December 2020

The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins

1 reference

12 December 2020

Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia

1 reference

12 December 2020

Nonalcoholic fatty liver disease: a clinical review

1 reference

12 December 2020

Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase.

1 reference

12 December 2020

Apolipoprotein A-V-heparin interactions: implications for plasma lipoprotein metabolism

1 reference

12 December 2020

Determination of the functionality of common APOA5 polymorphisms

1 reference

12 December 2020

A genetic variant c.553G > T in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and altered triglyceride levels in a Chinese population

1 reference

12 December 2020

Give me A5 for lipoprotein hydrolysis!

1 reference

12 December 2020

Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment

1 reference

12 December 2020

Lipid droplets: a unified view of a dynamic organelle

1 reference

12 December 2020

Ins and outs modulating hepatic triglyceride and development of nonalcoholic fatty liver disease

1 reference

12 December 2020

Plasma apolipoprotein A5 and triglycerides in type 2 diabetes

1 reference

12 December 2020

The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II.

1 reference

12 December 2020

Apolipoprotein A-V interaction with members of the low density lipoprotein receptor gene family

1 reference

12 December 2020

Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons

1 reference

12 December 2020

Apolipoprotein A-V association with intracellular lipid droplets

1 reference

12 December 2020

Characterization of apolipoprotein A-V structure and mode of plasma triacylglycerol regulation

1 reference

12 December 2020

The genetics of nonalcoholic fatty liver disease.

1 reference

12 December 2020

Lipid droplets in lipogenesis and lipolysis

1 reference

12 December 2020

Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease.

1 reference

12 December 2020

The functional interaction on in vitro gene expression of APOA5 SNPs, defining haplotype APOA52, and their paradoxical association with plasma triglyceride but not plasma apoAV levels

1 reference

12 December 2020

An apolipoprotein A-V gene SNP is associated with marked hypertriglyceridemia among Asian-American patients

1 reference

12 December 2020

Intracellular lipid droplet targeting by apolipoprotein A-V requires the carboxyl-terminal segment

1 reference

12 December 2020

Nonalcoholic fatty liver disease

1 reference

12 December 2020

Orphan nuclear receptor Nur77 participates in human apolipoprotein A5 gene expression

1 reference

12 December 2020

Apolipoprotein A-V associates with intrahepatic lipid droplets and influences triglyceride accumulation

1 reference

12 December 2020

Recent advances in nonalcoholic fatty liver disease

1 reference

12 December 2020

Intravenous injection of apolipoprotein A-V reconstituted high-density lipoprotein decreases hypertriglyceridemia in apoav-/- mice and requires glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1.

1 reference

12 December 2020

Genetic determinants of plasma triglycerides

1 reference

12 December 2020

Biogenesis of apolipoprotein A-V and its impact on VLDL triglyceride secretion

1 reference

12 December 2020

The role of apolipoprotein A5 in non-alcoholic fatty liver disease

1 reference

12 December 2020

Apolipoprotein A-V dependent modulation of plasma triacylglycerol: a puzzlement

1 reference

12 December 2020

The proteomics of lipid droplets: structure, dynamics, and functions of the organelle conserved from bacteria to humans

1 reference

12 December 2020

Nonalcoholic fatty liver disease/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment

1 reference

12 December 2020

Influence of apolipoprotein A-V on hepatocyte lipid droplet formation

1 reference

12 December 2020

Optimized signal peptides for the development of high expressing CHO cell lines

1 reference

12 December 2020

Influence of apolipoprotein A-V on the metabolic fate of triacylglycerol

1 reference

12 December 2020

Apolipoprotein A5 deficiency aggravates high-fat diet-induced obesity due to impaired central regulation of food intake.

1 reference

12 December 2020

Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans

1 reference

12 December 2020

Homozygosity for a partial deletion of apoprotein A-V signal peptide results in intracellular missorting of the protein and chylomicronemia in a breast-fed infant

1 reference

12 December 2020

Aberrant hetero-disulfide bond formation by the hypertriglyceridemia-associated p.Gly185Cys APOA5 variant (rs2075291).

1 reference

12 December 2020

Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction

1 reference

12 December 2020

ApoA5 knockdown improves whole-body insulin sensitivity in high-fat-fed mice by reducing ectopic lipid content.

1 reference

12 December 2020

Increased apolipoprotein A5 expression in human and rat non-alcoholic fatty livers

1 reference

12 December 2020

10.2174/1389450116666150531161138

Identifiers

DOI

1 reference

30 June 2019

PMCID

6594035

1 reference

30 June 2019

PubMed ID

26028042

1 reference

30 June 2019